Developer docs
API playgroundTry for free, no card

Search company profiles

ENOUGH

Full company profile

uuid0000ihz

Namestring
ENOUGH
Legal namestring
ENOUGH B.V.
Websiteurl
enough-food.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

ENOUGH (formerly 3F BIO) is a UK-headquartered food technology company that produces ABUNDA mycoprotein — a fermented fungal protein — through a proprietary zero-waste fermentation process in which fungi are fed naturally-occurring sugars in grains. Founded in 2015 and headquartered in Glasgow, Scotland, the company operates from four locations: its UK headquarters in Glasgow, an office in London, a Dutch operating entity (ENOUGH B.V., registered in Zoetermeer), and a 15,000 square metre flagship production facility in Sas van Gent, the Netherlands, co-located alongside a Cargill site. The firm employs 51-100 people and has raised over €95 million across six funding rounds between 2017 and 2024.

The company's core technology is a patented zero-waste fungal fermentation process yielding a whole-biomass mycoprotein with all nine essential amino acids, zinc, iron and fibre, and a fibrous meat-like texture. Documented efficiency claims versus beef are 97% lower feed use, 99% lower water use and 95% lower CO2 emissions; the company reports its process is 3-15x more feed-conversion-efficient than competing protein sources. Initial facility capacity is 10,000 tonnes per annum, with a stated ramp to 60,000 tonnes by 2027 and a long-term vision of 1 million tonnes of cumulative mycoprotein output by 2032-2033.

ENOUGH operates a B2B ingredient model, selling ABUNDA mycoprotein to food manufacturers, CPG companies and retailers for incorporation into burgers, chicken-style products, seafood alternatives, noodles and snacks. Pricing is negotiated through multi-year commercial agreements rather than publicly disclosed. Named enterprise customers are Unilever (including through The Vegetarian Butcher brand), Marks & Spencer, and Cargill; Cargill has also signed a commercial agreement to use and market ABUNDA, supplies feedstock and utilities to the Sas van Gent site, and has participated in multiple funding rounds. Distribution is therefore split between direct B2B sales and Cargill's global ingredient network.

Short descriptiontext

ENOUGH (formerly 3F BIO) is a UK-based food technology company that produces ABUNDA mycoprotein via proprietary zero-waste fungal fermentation, supplying it as a B2B ingredient to food manufacturers, CPG companies and retailers including Unilever, Marks & Spencer and Cargill.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersGlasgow, United Kingdom
HQ citystring
Glasgow
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fermented protein ingredients, mycoprotein production, sustainable food ingredients, alternative protein supply, fungal fermentation technology
Industry3 codes
1Mycoprotein-Based Foods Manufacturing
CodeAFAKAGAGPrimaryYes
2Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based)
CodeAFAJAHAEPrimaryNo
3Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation)
CodeAFAJAHAHPrimaryNo
NAICS code1 code
  • Food Manufacturing311
SIC code2 codes
  • Miscellaneous Food Preparations & Kindred Products2090
  • Food And Kindred Products2000
Product category
Alternative Protein Ingredients
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Ingredient Sales
TypeOne Time License
Description

ENOUGH is a B2B ingredient company that sells ABUNDA mycoprotein to food manufacturers, retailers, and brands. Revenue is generated through the sale of mycoprotein as an ingredient for incorporation into various food products including burgers, chicken-style products, noodles, snacks, and other applications.

enough-food.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1B2B ingredient pricing through commercial agreements
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is negotiated through commercial agreements with food manufacturers and retailers. No public pricing available.

enough-food.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1ABUNDA
Description

ABUNDA mycoprotein is ENOUGH's flagship fermented food ingredient, rich in protein and fibre with all 9 essential amino acids, zinc and iron. It provides a meaty texture and is used in various food products including burgers, chicken-style products, sausages, noodles, and snacks. ABUNDA is marketed as a sustainable protein alternative requiring 97% less feed than red meat, 99% less water than red meat, and emitting 95% less CO2 than red meat production.

enough-food.com
+1 more record
Core offering1 text field

ENOUGH produces and supplies ABUNDA mycoprotein, a fermented food ingredient made via a proprietary zero-waste fungal fermentation process, to food manufacturers, CPG companies, and retailers as a sustainable alternative protein. The B2B ingredient has a fibrous meat-like texture and contains all 9 essential amino acids, fiber, zinc, and iron, suitable for incorporation into burgers, chicken-style products, noodles, snacks, and seafood alternatives. Production takes place at a flagship facility in Sas van Gent, Netherlands, co-located with Cargill.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 97% less feed required compared to beef production
+7 more records
Product overview1 text field

ENOUGH is a food technology company specializing in large-scale, sustainable protein production through fungal fermentation. The company's primary product is ABUNDA mycoprotein, a fermented food ingredient produced via a proprietary zero-waste process. ENOUGH operates as a B2B ingredient supplier, working with retailers and brands to bring sustainable protein products to market. The company has developed production facilities in the Netherlands and maintains offices in Glasgow, UK and London. ABUNDA serves as an ingredient for various food applications including meat alternatives, seafood alternatives, and general protein-enriched foods.

Product and service1 record
1ABUNDA Mycoprotein
CategoryAlternative protein ingredient
Description

A fermented food ingredient produced through a zero-waste fungal fermentation process, rich in protein and fiber with all 9 essential amino acids, zinc, and iron. Offers a fibrous, meat-like texture suitable for vegan, vegetarian, and flexitarian diets, and is used in applications from burgers to chicken-style products, noodles, snacks, and seafood alternatives.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-15
Description

Cargill has expanded its relationship with ENOUGH by signing a commercial agreement to use and market ABUNDA mycoprotein and investing in ENOUGH's Series C growth funding round. ENOUGH's production facility is co-located alongside Cargill's facility in Sas van Gent, Netherlands. Cargill supplies ENOUGH with feedstock and utilities. This is a multi-faceted strategic partnership supporting ENOUGH's goal to produce 1 million tonnes of ABUNDA by 2033.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Unilever partners with ENOUGH for protein innovation using ABUNDA mycoprotein, including through The Vegetarian Butcher brand. This is described as a 'game changing' partnership for sustainable protein innovation.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

Marks & Spencer partnered with 3F BIO (ENOUGH) to develop a vegan range using mycoprotein as part of their Innovation Hub focused on disruptive innovation.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

The PLENITUDE consortium project involves 10 partners from the full value chain, with the aim of increasing availability of sustainable, safe food-grade protein. Cargill is one of the partners in this EU-funded project.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

ENOUGH is featured in EIT Foods content and videos on alternative proteins, supporting the biotech disruption in food.

Strategic tierSupportingTypeOthers
Description

ENOUGH is a founding member of the Fungi Protein Association (FPA), along with Quorn, Nature's Fynd, The Better Meat Co., The Protein Brewery, Prime Roots, Mycotechnology, Mycorena, and others. The FPA advocates for fungi as a sustainable protein in public policy and conducts consumer research.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Quorn is the incumbent mycoprotein producer with decades of brand equity and global retail distribution. It is the most directly comparable peer to ENOUGH's ABUNDA, producing fungal-fermented protein for meat alternative applications and competing for the same CPG and retail customers.

TypeDirect peer
Description

Nature's Fynd produces fungal protein (Fy) using biomass fermentation from a strain originally found in Yellowstone. It is a direct mycoprotein peer competing for the same B2B ingredient customers in the alternative protein category.

TypeDirect peer
Description

The Better Meat Co. produces a mycoprotein ingredient via fungal fermentation for use in hybrid and plant-based meat products. It is a fellow founding member of the Fungi Protein Association and a direct ingredient peer to ENOUGH in the mycoprotein category.

TypeEmerging player
Description

Mycorena is a Swedish food tech company producing mycoprotein via fungal fermentation (Promyc). It is an emerging mycoprotein peer focused on the European market, with a smaller commercial scale than ENOUGH.

TypeEmerging player
Description

Prime Roots produces mycelium-based whole-cut meat alternatives using fungal biomass fermentation. It is an emerging direct peer in the fungal protein category, focused on deli slices, jerky, and other whole-cut applications.

TypeEmerging player
Description

The Protein Brewery produces fungal fermentation-derived protein (FUMI) for food applications. It is an emerging direct peer with overlapping technology and target customers in the alternative protein B2B space.

TypeEmerging player
Description

MycoTechnology uses fungal fermentation platforms to create food ingredients, including mycelium-based protein and flavor-masking solutions. It is a fellow Fungi Protein Association member and an emerging peer with related fermentation technology.

TypeEmerging player
Description

Meati produces whole-food protein from mushroom root (mycelium) for plant-based meat alternatives. It is an emerging peer in the mycelium/fungal protein category, competing for consumer-facing shelf space and B2B ingredient partnerships.

TypeBroad incumbent
Description

Beyond Meat is the largest publicly-traded plant-based meat alternative company. While it uses pea protein rather than mycoprotein, it is the dominant incumbent in the broader alternative protein category that ENOUGH's customers compete within at retail.

TypeBroad incumbent
Description

Impossible Foods produces plant-based meat alternatives using soy protein and heme. As a broad incumbent in the alternative protein category, it competes for the same foodservice and retail customers that ENOUGH's CPG partners serve.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors15 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ENOUGH

Alternative Protein Ingredientsenough-food.com

ENOUGH (formerly 3F BIO) is a UK-based food technology company that produces ABUNDA mycoprotein via proprietary zero-waste fungal fermentation, supplying it as a B2B ingredient to food manufacturers, CPG companies and retailers including Unilever, Marks & Spencer and Cargill.

What ENOUGH does

ENOUGH (formerly 3F BIO) is a UK-headquartered food technology company that produces ABUNDA mycoprotein — a fermented fungal protein — through a proprietary zero-waste fermentation process in which fungi are fed naturally-occurring sugars in grains. Founded in 2015 and headquartered in Glasgow, Scotland, the company operates from four locations: its UK headquarters in Glasgow, an office in London, a Dutch operating entity (ENOUGH B.V., registered in Zoetermeer), and a 15,000 square metre flagship production facility in Sas van Gent, the Netherlands, co-located alongside a Cargill site. The firm employs 51-100 people and has raised over €95 million across six funding rounds between 2017 and 2024.

The company's core technology is a patented zero-waste fungal fermentation process yielding a whole-biomass mycoprotein with all nine essential amino acids, zinc, iron and fibre, and a fibrous meat-like texture. Documented efficiency claims versus beef are 97% lower feed use, 99% lower water use and 95% lower CO2 emissions; the company reports its process is 3-15x more feed-conversion-efficient than competing protein sources. Initial facility capacity is 10,000 tonnes per annum, with a stated ramp to 60,000 tonnes by 2027 and a long-term vision of 1 million tonnes of cumulative mycoprotein output by 2032-2033.

ENOUGH operates a B2B ingredient model, selling ABUNDA mycoprotein to food manufacturers, CPG companies and retailers for incorporation into burgers, chicken-style products, seafood alternatives, noodles and snacks. Pricing is negotiated through multi-year commercial agreements rather than publicly disclosed. Named enterprise customers are Unilever (including through The Vegetarian Butcher brand), Marks & Spencer, and Cargill; Cargill has also signed a commercial agreement to use and market ABUNDA, supplies feedstock and utilities to the Sas van Gent site, and has participated in multiple funding rounds. Distribution is therefore split between direct B2B sales and Cargill's global ingredient network.

ENOUGH firmographics

Firmographics
Name
ENOUGH
Legal name
ENOUGH B.V.
Website
https://enough-food.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
ENOUGH (formerly 3F BIO) is a UK-based food technology company that produces ABUNDA mycoprotein via proprietary zero-waste fungal fermentation, supplying it as a B2B ingredient to food manufacturers, CPG companies and retailers including Unilever, Marks & Spencer and Cargill.
Ownership category
akta.pro rank

ENOUGH industry classification

Industry
Product category
Alternative Protein Ingredients
NAICS
Food Manufacturing (311)
SIC
Miscellaneous Food Preparations & Kindred Products (2090), Food And Kindred Products (2000)
akta.pro primary industry
Mycoprotein-Based Foods Manufacturing (AFAKAGAG)
akta.pro secondary industries
Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based) (AFAJAHAE), Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation) (AFAJAHAH)

Keywords

  • Fermented protein ingredients
  • Mycoprotein production
  • Sustainable food ingredients
  • Alternative protein supply
  • Fungal fermentation technology

Where ENOUGH is headquartered

Location

Headquarters

HQ city
Glasgow
HQ country
United Kingdom
HQ region
Europe

Offices4 records

Markets served

ENOUGH business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. B2B Ingredient Sales: ENOUGH is a B2B ingredient company that sells ABUNDA mycoprotein to food manufacturers, retailers, and brands. Revenue is generated through the sale of mycoprotein as an ingredient for incorporation into various food products including burgers, chicken-style products, noodles, snacks, and other applications.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B ingredient pricing through commercial agreements

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

ENOUGH product offering

Product offering

Core offering

ENOUGH produces and supplies ABUNDA mycoprotein, a fermented food ingredient made via a proprietary zero-waste fungal fermentation process, to food manufacturers, CPG companies, and retailers as a sustainable alternative protein. The B2B ingredient has a fibrous meat-like texture and contains all 9 essential amino acids, fiber, zinc, and iron, suitable for incorporation into burgers, chicken-style products, noodles, snacks, and seafood alternatives. Production takes place at a flagship facility in Sas van Gent, Netherlands, co-located with Cargill.

Product overview

ENOUGH is a food technology company specializing in large-scale, sustainable protein production through fungal fermentation. The company's primary product is ABUNDA mycoprotein, a fermented food ingredient produced via a proprietary zero-waste process. ENOUGH operates as a B2B ingredient supplier, working with retailers and brands to bring sustainable protein products to market. The company has developed production facilities in the Netherlands and maintains offices in Glasgow, UK and London. ABUNDA serves as an ingredient for various food applications including meat alternatives, seafood alternatives, and general protein-enriched foods.

Differentiator

Problem solved

Functional benefit

Brands

  • ABUNDA: ABUNDA mycoprotein is ENOUGH's flagship fermented food ingredient, rich in protein and fibre with all 9 essential amino acids, zinc and iron. It provides a meaty texture and is used in various food products including burgers, chicken-style products, sausages, noodles, and snacks. ABUNDA is marketed as a sustainable protein alternative requiring 97% less feed than red meat, 99% less water than red meat, and emitting 95% less CO2 than red meat production.
  • ABUNDA®

Products and services

  • ABUNDA Mycoprotein A fermented food ingredient produced through a zero-waste fungal fermentation process, rich in protein and fiber with all 9 essential amino acids, zinc, and iron. Offers a fibrous, meat-like texture suitable for vegan, vegetarian, and flexitarian diets, and is used in applications from burgers to chicken-style products, noodles, snacks, and seafood alternatives.

Quantifiable outcome

  • 97% less feed required compared to beef production
  • +7 more outcomes

Companies that use ENOUGH

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

ENOUGH technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

ENOUGH partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, key and supporting.

  • CargillcoreStrategic or Co-development Partner · 15 February 2024Cargill has expanded its relationship with ENOUGH by signing a commercial agreement to use and market ABUNDA mycoprotein and investing in ENOUGH's Series C growth funding round. ENOUGH's production facility is co-located alongside Cargill's facility in Sas van Gent, Netherlands. Cargill supplies ENOUGH with feedstock and utilities. This is a multi-faceted strategic partnership supporting ENOUGH's goal to produce 1 million tonnes of ABUNDA by 2033.
  • UnilevercoreStrategic or Co-development PartnerUnilever partners with ENOUGH for protein innovation using ABUNDA mycoprotein, including through The Vegetarian Butcher brand. This is described as a 'game changing' partnership for sustainable protein innovation.
  • Marks & SpencerkeyStrategic or Co-development PartnerMarks & Spencer partnered with 3F BIO (ENOUGH) to develop a vegan range using mycoprotein as part of their Innovation Hub focused on disruptive innovation.
  • PLENITUDE ConsortiumkeyStrategic or Co-development PartnerThe PLENITUDE consortium project involves 10 partners from the full value chain, with the aim of increasing availability of sustainable, safe food-grade protein. Cargill is one of the partners in this EU-funded project.
  • EIT FoodssupportingStrategic or Co-development PartnerENOUGH is featured in EIT Foods content and videos on alternative proteins, supporting the biotech disruption in food.
  • Fungi Protein AssociationsupportingOthersENOUGH is a founding member of the Fungi Protein Association (FPA), along with Quorn, Nature's Fynd, The Better Meat Co., The Protein Brewery, Prime Roots, Mycotechnology, Mycorena, and others. The FPA advocates for fungi as a sustainable protein in public policy and conducts consumer research.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

ENOUGH competitors and assessment

Company assessment

Direct peers

  • Quorn: Quorn is the incumbent mycoprotein producer with decades of brand equity and global retail distribution. It is the most directly comparable peer to ENOUGH's ABUNDA, producing fungal-fermented protein for meat alternative applications and competing for the same CPG and retail customers.
  • Nature's Fynd: Nature's Fynd produces fungal protein (Fy) using biomass fermentation from a strain originally found in Yellowstone. It is a direct mycoprotein peer competing for the same B2B ingredient customers in the alternative protein category.
  • The Better Meat Co. The Better Meat Co. produces a mycoprotein ingredient via fungal fermentation for use in hybrid and plant-based meat products. It is a fellow founding member of the Fungi Protein Association and a direct ingredient peer to ENOUGH in the mycoprotein category.

Emerging players

  • Mycorena: Mycorena is a Swedish food tech company producing mycoprotein via fungal fermentation (Promyc). It is an emerging mycoprotein peer focused on the European market, with a smaller commercial scale than ENOUGH.
  • Prime Roots: Prime Roots produces mycelium-based whole-cut meat alternatives using fungal biomass fermentation. It is an emerging direct peer in the fungal protein category, focused on deli slices, jerky, and other whole-cut applications.
  • The Protein Brewery: The Protein Brewery produces fungal fermentation-derived protein (FUMI) for food applications. It is an emerging direct peer with overlapping technology and target customers in the alternative protein B2B space.
  • MycoTechnology: MycoTechnology uses fungal fermentation platforms to create food ingredients, including mycelium-based protein and flavor-masking solutions. It is a fellow Fungi Protein Association member and an emerging peer with related fermentation technology.
  • Meati Foods: Meati produces whole-food protein from mushroom root (mycelium) for plant-based meat alternatives. It is an emerging peer in the mycelium/fungal protein category, competing for consumer-facing shelf space and B2B ingredient partnerships.

Broad incumbents

  • Beyond Meat: Beyond Meat is the largest publicly-traded plant-based meat alternative company. While it uses pea protein rather than mycoprotein, it is the dominant incumbent in the broader alternative protein category that ENOUGH's customers compete within at retail.
  • Impossible Foods: Impossible Foods produces plant-based meat alternatives using soy protein and heme. As a broad incumbent in the alternative protein category, it competes for the same foodservice and retail customers that ENOUGH's CPG partners serve.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ENOUGH social profiles

Digital presence

ENOUGH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ENOUGH leadership team

Management profile

Number of profiles

Profiles3 records

ENOUGH funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ENOUGH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ENOUGH

What does ENOUGH do?

ENOUGH produces and supplies ABUNDA mycoprotein, a fermented food ingredient made via a proprietary zero-waste fungal fermentation process, to food manufacturers, CPG companies, and retailers as a sustainable alternative protein. The B2B ingredient has a fibrous meat-like texture and contains all 9 essential amino acids, fiber, zinc, and iron, suitable for incorporation into burgers, chicken-style products, noodles, snacks, and seafood alternatives. Production takes place at a flagship facility in Sas van Gent, Netherlands, co-located with Cargill.

Is ENOUGH a public or private company?

ENOUGH is a private company. It is classified as venture growth investor backed and is currently operating.

When was ENOUGH founded?

ENOUGH was founded in 2015. It employs 51 to 100 people.

Where is ENOUGH based?

ENOUGH is headquartered in Glasgow, United Kingdom, in the Europe region.

How does ENOUGH make money?

One revenue line is on record: B2B Ingredient Sales.

Who are ENOUGH's main competitors?

Direct peers on record are Quorn, Nature's Fynd and The Better Meat Co.. Emerging players are Mycorena, Prime Roots, The Protein Brewery, MycoTechnology and Meati Foods. Broad incumbents are Beyond Meat and Impossible Foods.

Does ENOUGH have an API?

No public API is recorded for ENOUGH.

What industry is ENOUGH in?

ENOUGH's product category is Alternative Protein Ingredients. Its primary akta.pro industry code is AFAKAGAG, Mycoprotein-Based Foods Manufacturing, with a secondary code of AFAJAHAE, Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based). Its NAICS code is 311 and its SIC code is 2090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Market Research & Business IntelligenceExplore the Global Mycoprotein Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036Future Market Insights published a market analysis forecasting the global mycoprotein market to grow from USD 791.0 million in 2026 to USD 1,458.0 million by 2036, representing a 6.3% CAGR, with minced mycoprotein leading product formats at 30% share and meat alternatives the top end-use segment at 28%. The UK is projected to be the fastest-growing country at 6.4% CAGR, followed by China at 6.0% and the USA at 5.8%, driven by fermentation investment, consumer familiarity with meat-free products, and expanding retail presence. Key players identified include Quorn Foods, ENOUGH, Nature's Fynd, The Better Meat Co., Infinite Roots, Naplasol, and MyForest Foods, with the competitive landscape remaining moderately concentrated but seeing entry from specialist fermentation firms and ingredient suppliers.EIN PresswireFermented Protein Market Size & Share Report 2026–2036: 12.6% CAGR to Drive USD 12.4 billion ValuationThe global fermented protein market is projected to expand from USD 3.8 billion in 2026 to USD 12.4 billion by 2036, reflecting a 12.6% CAGR driven by demand for sustainable protein sources and advances in precision fermentation technology. Key commercial milestones include The EVERY Company's USD 55 million Series D funding and strategic partnerships such as Cargill-ENOUGH and the Abu Dhabi Investment Office facility deal, signaling the sector's transition from venture experimentation to infrastructure-backed expansion. The industry faces cost and scalability challenges, with precision fermentation proteins currently priced 3–10 times higher than conventional alternatives, positioning 2026–2036 as a consolidation phase for companies unable to achieve commercial-scale production.Persistence Market ResearchFunctional Food Ingredients Market Size & Forecast, 2032The global functional food ingredients market is projected to grow from US$120.0 billion in 2025 to US$190.2 billion by 2032, driven by rising health consciousness and demand for fortified products. Key industry developments include Cargill's partnership with ENOUGH for fermented proteins and DuPont's expansion of probiotics production capacity.ScotsmanEdinburgh spearheads 'scale-up' business systemEdinburgh is spearheading Scotland's scale-up business ecosystem, with 625 established scale-ups and 265 additional ventures in the pipeline. Collectively, Glasgow and Edinburgh's scale-up sectors generate a combined annual turnover exceeding £41 billion, while scale-ups nationwide employ nearly 1 million people and contribute £500 billion in annual turnover. Innovative companies such as Edinburgh-based CUU International and Glasgow-based Enough are driving sustainable business practices through carbon capture technology and plant-based protein solutions respectively.businessInsider115 Scottish firms shared £359 million of venture capital during 2023A KPMG report indicates that 115 Scottish firms received over £359 million in venture capital during 2023, marking a significant decline from the record levels of £707 million and £628 million in the previous two years. The slowdown reflects increased investor caution globally, with notable deals including investments in ENOUGH, Manus Neurodynamica, and DirectID.GlobalaginvestingCargill Joins Growth Funding Round for ENOUGH, Agrees to Use and Market its MycoproteinCargill has joined a growth funding round for food tech company ENOUGH and signed a commercial agreement to use and market ABUNDA, its mycoprotein product. This expansion of their partnership involves Cargill leveraging its supply chain and formulation capabilities to help ENOUGH scale production in Europe and beyond. The collaboration aims to address global protein demand sustainably by utilizing fungi fermentation technology fed by Cargill's glucose syrup.TechCrunchFood tech roundup: Plant-based protein eaters still want it to taste like meatTechCrunch's food tech roundup highlights a strong 2022 for plant-based proteins, with U.S. broadline distributor sales reaching $304 million (up 8% from pre-pandemic levels) and analog plant-based products capturing 53% of pound sales, up from 39% in 2019, signaling consumer preference for meat-like alternatives. Two European cultivated protein companies secured significant funding: Scotland-based Enough raised €40 million ($43.5 million) to double its mycoprotein production capacity, while Meatable raised $35 million to accelerate its cultivated pork products, claiming production time reductions from three weeks to eight days. The roundup also briefly mentions several other startups working on plant-based alternatives, including Black Sheep Foods, Rebellyous, and New Culture, suggesting continued investor interest in the alternative protein sector.PR NewswireSteakholder Foods™ Reports Financial Results for Q2 2022 and Provides Business UpdateSteakholder Foods Ltd. reported Q2 2022 financial results showing an operating loss of $4.8 million, a 37% increase from Q2 2021, alongside a total comprehensive loss of $6.6 million, driven by rising R&D, marketing, and G&A expenses. The company completed a $6.5 million registered direct offering in early Q3 2022, bringing its cash position to approximately $14.2 million pro forma, after cash declined 56% to $8.4 million by June 30. Business highlights include a strategic agreement with ENOUGH, collaboration with Singapore's Umami Meats, the first patent grant from IP Australia, and rebranding from MeaTech 3D to Steakholder Foods.PR NewswireMeaTech Reports Financial Results for Q1 2022 and Provides Business UpdateMeaTech 3D Ltd. reported a Q1 2022 operating loss of $5.3 million, a 26% increase from the prior year period, driven by 90% higher R&D expenses ($2.1 million) and 228% higher marketing expenses ($1.1 million) as the company accelerates investment in cultured meat technology. The company achieved several milestones during the quarter including successful muscle stem cell differentiation with a patent filed with the USPTO, a new headquarters opening in Rehovot, Israel, plans to open a US office, and a Belgian pilot plant under subsidiary Peace of Meat. MeaTech also announced a multi-nozzle 3D bioprinting system for industrial-scale production and signed a strategic agreement with ENOUGH to develop hybrid alternative meat products.PR NewswireMeaTech's Belgian Subsidiary Establishes Stable and Unique Avian Cell Line with Clear Upscaling PathMeaTech 3D Ltd. announced that its Belgian wholly-owned subsidiary Peace of Meat has established a stable and unique avian cell line with a clear path toward commercialization in the hybrid foods market. The company signed a joint development agreement with mycoprotein leader ENOUGH in May 2022 to create hybrid alternative meat products combining plant-based ingredients with cultured avian biomass. Peace of Meat, acquired by MeaTech in 2021 for approximately $20 million, successfully produced 700 grams of cultured chicken fat biomass in September 2021 and plans to establish a pilot plant in Belgium for scaled-up production in 2023.